BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22259221)

  • 1. Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells.
    Zhou P; Lu Y; Sun XH
    Mol Vis; 2012; 18():22-8. PubMed ID: 22259221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2.
    Zhou P; Lu Y; Sun XH
    Mol Vis; 2011; 17():2717-23. PubMed ID: 22065925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells.
    Zhang C; Liu J; Jin N; Zhang G; Xi Y; Liu H
    PLoS One; 2016; 11(12):e0167349. PubMed ID: 27911920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.
    Chandler HL; Webb TR; Barden CA; Thangavelu M; Kulp SK; Chen CS; Colitz CM
    Mol Vis; 2010 Oct; 16():2202-14. PubMed ID: 21139685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
    Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification.
    Awasthi N; Wagner BJ
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4482-9. PubMed ID: 17003443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bit1-a potential positive regulator of epithelial-mesenchymal transition in lens epithelial cells.
    Wu X; Ruan J; Ma B; Luo M
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1311-8. PubMed ID: 27122244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.
    Xie L; Santhoshkumar P; Reneker LW; Sharma KK
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4731-40. PubMed ID: 24994865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.
    Sureshkumar J; Haripriya A; Muthukkaruppan V; Kaufman PL; Tian B
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):507-14. PubMed ID: 22138731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
    Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Inhibits Wound Healing and Lens Fibrosis: A Putative Candidate for Posterior Capsule Opacification Prevention.
    Smith AJO; Eldred JA; Wormstone IM
    Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3863-3877. PubMed ID: 31529119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification.
    Awasthi N; Wang-Su ST; Wagner BJ
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1998-2003. PubMed ID: 18436832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
    Jiang Q; Zhou C; Bi Z; Wan Y
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):93-102. PubMed ID: 16722795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification.
    Eibl KH; Liegl R; Kernt M; Priglinger S; Kampik A
    J Cataract Refract Surg; 2009 May; 35(5):900-5. PubMed ID: 19393891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro.
    Bryan JN; Kumar SR; Jia F; Balkin ER; Lewis MR
    Cell Biol Int; 2014 Feb; 38(2):187-97. PubMed ID: 24323360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
    Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
    Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing two birds with one stone: dual blockade of integrin and FGF signaling through targeting syndecan-4 in postoperative capsular opacification.
    Qin Y; Zhu Y; Luo F; Chen C; Chen X; Wu M
    Cell Death Dis; 2017 Jul; 8(7):e2920. PubMed ID: 28703800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of posterior capsular opacification through aldose reductase inhibition.
    Yadav UC; Ighani-Hosseinabad F; van Kuijk FJ; Srivastava SK; Ramana KV
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):752-9. PubMed ID: 19011011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP90 as a novel therapeutic target for posterior capsule opacification.
    Li J; Xue W; Wang X; Huang W; Wang XX; Li H; Cui X; Li M; Mu H; Ren Y; Zhang F; Hu Y
    Exp Eye Res; 2019 Dec; 189():107821. PubMed ID: 31589841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.